Antihemophilic Factor (Recombinant), Fc Fusion Protein

FDA Drug Profile — ELOCTATE

Antihemophilic Factor (Recombinant), Fc Fusion Protein is listed in the FDA National Drug Code directory with 10 NDC codes, marketed under brand name including ELOCTATE. Available dosage form: kit.

Drug Details

Generic Name
Antihemophilic Factor (Recombinant), Fc Fusion Protein
Brand Names
ELOCTATE
Application Number
BLA125487
Sponsor
Bioverativ Therapeutics Inc.
NDC Codes
10
Dosage Forms
KIT
Routes
INTRAVENOUS
Active Ingredients
N/A